Orai inhibition modulates pulmonary ILC2 metabolism and alleviates airway hyperreactivity in murine and humanized models.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
26 Sep 2023
26 Sep 2023
Historique:
received:
20
06
2022
accepted:
22
08
2023
medline:
27
11
2023
pubmed:
27
9
2023
entrez:
26
9
2023
Statut:
epublish
Résumé
Ca
Identifiants
pubmed: 37752127
doi: 10.1038/s41467-023-41065-4
pii: 10.1038/s41467-023-41065-4
pmc: PMC10522697
doi:
Substances chimiques
ORAI1 Protein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5989Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL159804
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Barlow, J. L. et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 132, 933–941 (2013).
pubmed: 23810766
Kim, H. Y. et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 129, 216–227.e1–6 (2012).
pubmed: 22119406
Mindt, B. C., Fritz, J. H. & Duerr, C. U. Group 2 innate lymphoid cells in pulmonary immunity and tissue homeostasis. Front. Immunol. 9, 840 (2018).
pubmed: 29760695
pmcid: 5937028
Bartemes, K. R. & Kita, H. Roles of innate lymphoid cells (ILCs) in allergic diseases: the 10-year anniversary for ILC2s. J. Allergy Clin. Immunol. 147, 1531–1547 (2021).
pubmed: 33965091
pmcid: 8114584
McKenzie, A. N. J. Type-2 innate lymphoid cells in asthma and allergy. Ann. Am. Thorac. Soc. 11, S263–S270 (2014).
pubmed: 25525730
pmcid: 4298972
Vaeth, M., Kahlfuss, S. & Feske, S. CRAC channels and calcium signaling in T cell-mediated immunity. Trends Immunol. 41, 878–901 (2020).
pubmed: 32711944
pmcid: 7985820
Clemens, R. A. & Lowell, C. A. CRAC channel regulation of innate immune cells in health and disease. Cell Calcium 78, 56–65 (2019).
pubmed: 30641250
pmcid: 8055042
Li, X. et al. CRAC channel controls the differentiation of pathogenic B cells in lupus nephritis. Front. Immunol. 12, 779560 (2021).
Lioudyno, M. I. et al. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc. Natl Acad. Sci. USA 105, 2011–2016 (2008).
pubmed: 18250319
pmcid: 2538873
Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179–185 (2006).
pubmed: 16582901
Di Capite, J. L., Bates, G. J. & Parekh, A. B. Mast cell CRAC channel as a novel therapeutic target in allergy. Curr. Opin. Allergy Clin. Immunol. 11, 33–38 (2011).
pubmed: 21150433
Vaeth, M. et al. ORAI2 modulates store-operated calcium entry and T cell-mediated immunity. Nat. Commun. 8, 14714 (2017).
pubmed: 28294127
pmcid: 5355949
Srikanth, S. & Gwack, Y. Orai1-NFAT signalling pathway triggered by T cell receptor stimulation. Mol. Cells 35, 182–194 (2013).
pubmed: 23483280
pmcid: 3887911
Wilhelm, C. et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213, 1409–1418 (2016).
pubmed: 27432938
pmcid: 4986525
Galle-Treger, L. et al. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function. J. Allergy Clin. Immunol. 145, 502–517.e5 (2020).
pubmed: 31738991
Howard, E. et al. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity. J. Allergy Clin. Immunol. 147, 1281–1295.e5 (2021).
pubmed: 32905799
Jadiya, P. et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer’s disease. Nat. Commun. 10, 3885 (2019).
pubmed: 31467276
pmcid: 6715724
Kaufmann, U. et al. Calcium signaling controls pathogenic Th17 cell-mediated inflammation by regulating mitochondrial function. Cell Metab. 29, 1104–1118.e6 (2019).
pubmed: 30773462
pmcid: 6506368
Kim, K.-D. et al. Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation. J. Immunol. 192, 110–122 (2014).
pubmed: 24307733
Ribas, V., García-Ruiz, C. & Fernández-Checa, J. C. Mitochondria, cholesterol and cancer cell metabolism. Clin. Transl. Med. 5, 22 (2016).
pubmed: 27455839
pmcid: 4960093
Angajala, A. et al. Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front. Immunol. 9, 1605 (2018).
pubmed: 30050539
pmcid: 6052888
Berthiaume, J. M., Kurdys, J. G., Muntean, D. M. & Rosca, M. G. Mitochondrial NAD+/NADH redox state and diabetic cardiomyopathy. Antiox. Redox Signal. 30, 375–398 (2019).
Li, X. et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol. 6, 19 (2013).
pubmed: 23442817
pmcid: 3599349
Hurrell, B. P. et al. Distinct roles of LFA-1 and ICAM-1 on ILC2s control lung infiltration, effector functions, and development of airway hyperreactivity. Front. Immunol. 11, 542818 (2020).
Shafiei-Jahani, P. et al. CD200-CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma. Nat. Commun. 12, 2526 (2021).
pubmed: 33953190
pmcid: 8100131
Ingley, E., Cutler, R. L., Fung, M.-C., Sanderson, C. J. & Young, I. G. Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems. Eur. J. Biochem. 196, 623–629 (1991).
pubmed: 2013285
Tavernier, J. et al. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc. Natl Acad. Sci. USA 92, 5194–5198 (1995).
pubmed: 7761472
pmcid: 41875
Holgate, S. T. & Polosa, R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8, 218–230 (2008).
pubmed: 18274559
Duffy, S. M. et al. The K+ channel iKCA1 potentiates Ca
Cruse, G., Duffy, S. M., Brightling, C. E. & Bradding, P. Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax 61, 880–885 (2006).
pubmed: 16809411
pmcid: 2104766
Olyaei, A. J., de Mattos, A. M. & Bennett, W. M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr. Opin. Crit. Care 7, 384–389 (2001).
pubmed: 11805539
Naesens, M., Kuypers, D. R. J. & Sarwal, M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 4, 481–508 (2009).
pubmed: 19218475
Grimes, D. et al. ORAI1 and ORAI2 modulate murine neutrophil calcium signaling, cellular activation, and host defense. PNAS 117, 24403–24414 (2020).
pubmed: 32929002
pmcid: 7533673
DebRoy, A. et al. Cooperative signaling via transcription factors NF-κB and AP1/c-Fos mediates endothelial cell STIM1 expression and hyperpermeability in response to endotoxin. J. Biol. Chem. 289, 24188–24201 (2014).
pubmed: 25016017
pmcid: 4148850
Marcu, R., Wiczer, B. M., Neeley, C. K. & Hawkins, B. J. Mitochondrial matrix Ca
pubmed: 24865966
pmcid: 4135570
Ballinger, S. W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 38, 1278–1295 (2005).
pubmed: 15855047
Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat. Immunol. 21, 1022–1033 (2020).
pubmed: 32661364
pmcid: 7442749
Tan, A. S., Baty, J. W. & Berridge, M. V. The role of mitochondrial electron transport in tumorigenesis and metastasis. Biochim. Biophys. Acta BBA - Gen. Subjects 1840, 1454–1463 (2014).
Orrenius, S., Gogvadze, V. & Zhivotovsky, B. Mitochondrial oxidative stress: implications for cell death. Ann. Rev. Pharmacol. Toxicol. 47, 143–183 (2007).
Srikanth, S. et al. The Ca
pubmed: 30643259
pmcid: 6340781
Akbari, O. et al. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J. Immunol. 180, 5448–5456 (2008).
pubmed: 18390727
Rigas, D. et al. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction. J. Allergy Immunol. 139, 1468–1477.e2 (2017).
Helou, D. G. et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat. Commun. 11, 3998 (2020).
pubmed: 32778730
pmcid: 7417739
Galle-Treger, L. et al. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. Nat. Commun. 7, 13202 (2016).
pubmed: 27752043
pmcid: 5071851
Wallrapp, A. et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature 549, 351–356 (2017).
pubmed: 28902842
pmcid: 5746044